Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 9 Issue 3

The Complex Bidirectional Relationship Between Sarcopenia and Tooth Loss: A Concise Review

Efsun Somay*

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey

*Corresponding Author: Efsun Somay, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey.

Received: January 17, 2025; Published: February 14, 2025

Abstract

Sarcopenia, defined as the progressive decline in skeletal muscle mass, strength, and functionality, has garnered considerable attention due to its associations with numerous adverse health outcomes. Emerging research suggests that sarcopenia may adversely affect oral health, particularly by leading to tooth loss, through shared risk factors such as aging, systemic inflammation, nutritional deficiencies, and compromised functional capacity. Sarcopenia may result in diminished chewing function, which can lead to a reduced intake of essential nutrients and an increased vulnerability to periodontal disease, all of which contribute to tooth loss. Conversely, the loss of teeth may exacerbate sarcopenia by limiting dietary diversity and impairing nutrient absorption, thereby accelerating muscle degeneration. Systemic inflammation, hormonal imbalances, and oxidative stress are additional significant factors that influence the interaction between sarcopenia and oral health. A comprehensive understanding of the implications of sarcopenia on tooth loss is essential for developing integrated healthcare strategies that address the interrelated nature of the musculoskeletal system and oral health. Considering the existing proof that indicates a complex bidirectional relationship between sarcopenia and tooth loss, this review seeks to provide a comprehensive, evidence-based summary addressing the definitions and measurement methodologies of sarcopenia, the shared pathophysiological mechanisms connecting sarcopenia and tooth loss, and the implications of these conditions on the overall health status of affected individuals.

 Keywords: Sarcopenia; Tooth Loss; Quality of Life

References

  1. Cruz-Jentoft AJ., et al. “Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) and the Extended Group for EWGSOP2. “Sarcopenia: revised European consensus on definition and diagnosis”. Age Ageing1 (2019): 16-31.
  2. Han CH., et al. “Association Between Sarcopenia and Tooth Loss”. Annals of Geriatric Medicine and Research 3 (2018): 145-150.
  3. Hyde S., et al. “Prevention of tooth loss and dental pain for reducing the global burden of oral diseases”. International Dental Journal 67 (2017): 19-25.
  4. Kotronia E., et al. “Oral health and all-cause, cardiovascular disease, and respiratory mortality in older people in the UK and USA”. Scientific Report1 (2021)16452.
  5. Kaurani P., et al. “Association of tooth loss and nutritional status in adults: an overview of systematic reviews”. BMC Oral Health1 (2024): 838.
  6. Larsson L., et al. “Sarcopenia: Aging-Related Loss of Muscle Mass and Function”. Physiology Review1 (2019): 427-511.
  7. Zhu Y and Hollis JH. “Tooth loss and its association with dietary intake and diet quality in American adults”. Journal of Dentistry11 (2014): 1428-1435.
  8. Bloomgarden Z. “Sarcopenia”. Journal of Diabetes10 (2024): e70025.
  9. Cruz-Jentoft AJ., et al. “Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People”. Age Ageing4 (2010): 412-423.
  10. Therakomen V., et al. “Prevalence and risk factors primary sarcopenia in community-dwelling outpatient elderly: a cross-sectional study”. Scientific Report 10 (2020):
  11. Muscaritoli M., al”. Consensus definition of sarcopenia, cachexia, and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics”. Clinical Nutrition 29 (2010): 154-159.
  12. Roubenoff R. “Origins and clinical relevance of sarcopenia”. Canadian Journal of Applied Physiology 26 (2001): 78-89.
  13. Rosenberg IH. “Sarcopenia: origins and clinical relevance”. Journal of Nutrition 127 (1997): 990S-991S.
  14. Janssen I., et al. “Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability”. Journal of the American Geriatrics Society 50 (2002): 889-896.
  15. Fielding RA., et al. “Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia”. Journal of the American Medical Directors Association 12 (2011): 249-256.
  16. Morley JE., et al. “Sarcopenia with limited mobility: an international consensus”. Journal of the American Medical Directors Association 12 (2011): 403-409.
  17. Chen LK., et al. “Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia”. Journal of the American Medical Directors Association 15 (2014): 95-101.
  18. Studenski SA., et al. “The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates”. The Journals of Gerontology: Series A 69 (2014): 547-558.
  19. McGregor, RA., et al. “It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life”. Longevity Health 3 (2014): 9.
  20. Malmstrom TK., et al. “SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes”. Journal of Cachexia, Sarcopenia and Muscle 7 (2016): 28-36.
  21. Bhasin S., et al. “Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium”. Journal of the American Geriatrics Society 68 (2020): 1410-1418.
  22. Mitsiopoulos N., et al. “Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography”. Journal of Applied Physiology 85 (1985): 115-122.
  23. Beaudart C., et al. “Sarcopenia in daily practice: assessment and management”. BMC Geriatrics 16 (2016): 170.
  24. Buckinx F., et al. “Pitfalls in the measurement of muscle mass: a need for a reference standard”. Journal of Cachexia, Sarcopenia and Muscle 9 (2018): 269-278.
  25. Masanes F., et al. “Cut-off points for muscle mass - not grip strength or gait speed - determine variations in sarcopenia prevalence”. Journal of Nutrional Health Aging 21 (2017): 825-829.
  26. Bhasin S., et al. “Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium”. Journal of the American Geriatrics Society 68 (2020): 1410-1418.
  27. Cawthon PM., et al. “Strong relation between muscle mass determined by D3-creatine dilution, physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men”. Journals of Gerontology Series A 74 (2019): 844-852.
  28. Prado CM., et al. Lean tissue imaging: a new era for nutritional assessment and intervention”. Journal of Parenteral and Enteral Nutrition 38 (2014): 940-953.
  29. Orwoll ES., et al. “The Importance of muscle versus fat mass in sarcopenic obesity: a re-evaluation using D3-Creatine muscle mass versus DXA lean mass measurements”. Journals of Gerontology Series A 75 (2020): 1362-1368.
  30. Bohannon RW. “Grip strength: an indispensable biomarker for older adults”. Clinical Interventions in Aging 14 (2019): 1681-1691.
  31. Ibrahim K. et al. “A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): study protocol”. Pilot Feasibility Studies 2 (2016): 27.
  32. Angulo J., et al. “Physical activity and exercise: strategies to manage frailty”. Redox Biology 35 (2020): 101513.
  33. Bruyere O., al. “Assessment of muscle mass, muscle strength and physical performance in clinical practice: an international survey”. European Geriatric Medicine 7 (2016): 243-246.
  34. Abellan van Kann G., et al. “Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force”. The Journal of Nutrition Health and Aging 13 (2009): 881-889.
  35. Hugo FN., et al. “Correlates of partial tooth loss and edentulism in the Brazilian elderly”. Community Dentistry and Oral Epidemiology 35 (2007): 224-232.
  36. Stenman U., et al. “Oral health-related quality of life--associations with oral health and conditions in Swedish 70-year-old individuals”. Gerodontology 29 (2012) :e440-6.
  37. Hanioka T., et al. “Association of total tooth loss with smoking, drinking alcohol and nutrition in elderly Japanese: analysis of national database”. Gerodontology 24 (2007): 87-92.
  38. Kaur G., et al. “Association between type 1 and type 2 diabetes with periodontal disease and tooth loss”. Journal of Clinical Periodontology 36 (2009): 765-774.
  39. Murakami M, et al. “Relationship between chewing ability and sarcopenia in Japanese community-dwelling older adults”. Geriatrics and Gerontology International 15 (2015): 1007-1012.
  40. Kono R. “Relationship between occlusal force and preventive factors for disability among community-dwelling elderly persons”. Nihon Ronen Igakkai Zasshi 46 (2009): 55-62.
  41. Okuyama N, et al. “Influence of dental occlusion on physical fitness decline in a healthy Japanese elderly population”. Archives of Gerontology and Geriatrics 52 (2011): 172-176.
  42. Bertolini M, Clark D. “Periodontal disease as a model to study chronic inflammation in aging”. Geroscience 4 (2024): 3695-3709.
  43. Rong YD., et al. “Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10”. BMC Geriatrics 18 (2018): 308.
  44. Ferrucci L., et al. “Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels”. Journal of the American Geriatrics Society 50 (2002): 1947-1954.
  45. Goodman MN. “Tumor necrosis factor induces skeletal muscle protein breakdown in rats”. American Journal of Physics5 (1991): E727-E730.
  46. Haddad F, et al. “IL-6-induced skeletal muscle atrophy”. Journal of Applied Physiology 98 (2005): 911-917.
  47. Toth MJ, et al. “ Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activation”. American Journal of Physiology-Endocrinology and Metabolism 5 (2005): E883-E891.
  48. Könönen E., et al. “Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues”. Journal of Clinical Medicine8 (2019): 1135.
  49. Cekici A., et al. “Inflammatory and immune pathways in the pathogenesis of periodontal disease”. Periodontology 2000 1 (2014): 57-80.
  50. Azzolino D, et al. “Poor Oral Health as a Determinant of Malnutrition and Sarcopenia”. Nutrients12 (2019): 2898.
  51. Feng X., et al. “Aging-related geniohyoid muscle atrophy is related to aspiration status in healthy older adults”. Journals of Gerontology Series A 68 (2013): 853-860.
  52. Ertekin C and Aydogdu I. “Neurophysiology of swallowing”. Clinical Neurophysiology 114 (2003): 2226-2244.
  53. Sakai K., al. “Relationship between tongue strength, lip strength, and nutrition-related sarcopenia in older rehabilitation inpatients: A cross-sectional study”. Clinical Interventions in Aging 12 (2017): 1207-1214.
  54. D′Aiuto F., al. “Oxidative stress, systemic inflammation, and severe periodontitis”. Journal of Dental Research 89 (2010): 1241-1246.
  55. Zorov DB., et al. “Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release” Physiology Review 94 (2014): 909-950.
  56. Fedorova M., et al. “Reversible and irreversible modifications of skeletal muscle proteins in a rat model of acute oxidative stress”. Biophys Acta 1792 (2009): 1185-1193.
  57. Scicchitano BM, al. “Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1”. Aging (Albany NY) 1.5 (2009): 451-457.
  58. Musarò A and Scicchitano BM. “Counteracting sarcopenia: the role of IGF-1 isoforms”. Aging (Albany NY). 11 (2019): 3410-3411.
  59. Li X., et al. “Roles of PRF and IGF-1 in promoting alveolar osteoblast growth and proliferation and molecular mechanism”. International Journal of Clinical and Experimental Pathology 3 (2018): 3294-3301.
  60. Raja S., et al. “Growth factors in periodontal regeneration”. International Journal of Dental Hygiene 7 (2009): 82-89.
  61. Chen FM, al. “Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres”. Journal of Control Release 114 (2006): 209.
  62. Wang F., et al. “Relationship between tooth loss and sarcopenia in suburban community-dwelling older adults in Shanghai and Tianjin of China”. Scientific Report1 (2022): 7618.
  63. Cheng CH, al. “Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover”. International Journal of Molecular Sciences 23.3 (2022): 1376.
  64. Sakuma K and Yamaguchi A. “Sarcopenia and age-related endocrine function”. International Journal of Endocrinology (2012): 127362.
  65. Su X., et al. “The association between sex hormones and periodontitis among American adults: A cross-sectional study”. Frontiers in Endocrinology (Lausanne) 14 (2023): 1125819.
  66. MacEntee MI and Donnelly LR. “Oral health and the frailty syndrome”. Periodontology 2000. 72.1 (2016): 135-141.
  67. van der Putten GJ., et al. “ The importance of oral health in (frail) elderly people - a review”. European Geriatric Medicine 4 (2013): 339-344.
  68. Lin WL., et al. “Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis”. Journal of Gastroenterology and Hepatology 39 (2024): 11:2250-2259.
  69. Topkan E., et al. “The presence of myopenia alone is not sufficient for a diagnosis of sarcopenia”. Japanese Journal of Radiology (2024).
  70. Hatta K and Ikebe K. “Association between oral health and sarcopenia: A literature review”. Journal of Prosthodontic Research 2 (2021): 131-136.
  71. Yoshida M and Tsuga K. “Sarcopenia and Mastication”. Current Oral Health Report 7 (2020): 179-187.
  72. Newton JP., et al. “Changes in human jaw muscles with age and dental state”. Gerodontology 10 (1993): 16-22.
  73. Umeki K, et al. “The relationship between masseter muscle thickness and appendicular skeletal muscle mass in Japanese community-dwelling elders: a cross-sectional study”. Archives of Gerontology and Geriatrics 78 (2018): 18-22.
  74. Okamoto N., et al. “Relationship between tooth loss, low masticatory ability, and nutritional indices in the elderly: a cross-sectional study”. BMC Oral Health 19 (2019): 110.
  75. Ikebe K., et al. “Association of bite force with ageing and occlusal support in older adults”. Journal of Dentistry 33 (2005): 131-137.
  76. Ohi T., et al. “Maximum occlusal force and incident functional disability in older adults: the Tsurugaya project”. JDR Clinical and Translational Research 3 (2018): 195-202.

Citation

Citation: Efsun Somay. “The Complex Bidirectional Relationship Between Sarcopenia and Tooth Loss: A Concise Review”. Acta Scientific Medical Sciences 9.3 (2025): 62-75.

Copyright

Copyright: © 2025 Efsun Somay. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US